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Abstract: The human telomeric G-quadruplex (G4) is an attractive target for developing anticancer
drugs. Natural products protoberberine alkaloids are known to bind human telomeric G4 and inhibit
telomerase. Among several structurally similar protoberberine alkaloids, epiberberine (EPI) shows
the greatest specificity in recognizing the human telomeric G4 over duplex DNA and other G4s.
Recently, NMR study revealed that EPI recognizes specifically the hybrid-2 form human telomeric
G4 by inducing large rearrangements in the 5′-flanking segment and loop regions to form a highly
extensive four-layered binding pocket. Using the NMR structure of the EPI-human telomeric G4
complex, here we perform molecular dynamics free energy calculations to elucidate the ligand
selectivity in the recognition of protoberberines by the human telomeric G4. The MM-PB(GB)SA
(molecular mechanics-Poisson Boltzmann/Generalized Born) Surface Area) binding free energies
calculated using the Amber force fields bsc0 and OL15 correlate well with the NMR titration and
binding affinity measurements, with both calculations correctly identifying the EPI as the strongest
binder to the hybrid-2 telomeric G4 wtTel26. The results demonstrated that accounting for the
conformational flexibility of the DNA-ligand complexes is crucially important for explaining the
ligand selectivity of the human telomeric G4. While the MD-simulated (molecular dynamics) structures
of the G-quadruplex-alkaloid complexes help rationalize why the EPI-G4 interactions are optimal
compared with the other protoberberines, structural deviations from the NMR structure near the
binding site are observed in the MD simulations. We have also performed binding free energy
calculation using the more rigorous double decoupling method (DDM); however, the results correlate
less well with the experimental trend, likely due to the difficulty of adequately sampling the very
large conformational reorganization in the G4 induced by the protoberberine binding.
Keywords: G-quadruplex; protoberberine; NMR; molecular dynamics simulation; binding free
energy; MM-PB(GB)SA; NMR titration
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1. Introduction
G-quadruplex DNA is a four-stranded non-canonical secondary structure formed in DNA
sequences containing consecutive runs of guanines such as d(TTAGGG)n in human telomeric DNA.
A G-quadruplex consists of stacked planar building blocks called G-tetrads, containing four guanines
connected by a network of Hoogsteen hydrogen bonding [1]. To form stable G-quadruplex, monovalent
cations K+ (or Na+) centrally located between the adjacent G-tetrad planes are required [2]. The human
telomere is a region of repetitive nucleotide sequences at the ends of chromosomes, which protects
the chromosome from degradation [3]. In normal cells, each cell replication results in a shortening
of the telomere, which will lead to apoptosis or programmed cell death when a critical shortening is
reached. However, in cancer cells the length of the telomere is extended by telomerase, which maintains
the malignant phenotype by stabilizing telomere length [4]. Intramolecular G-quadruplex formed
by the guanine-rich DNA sequences d(TTAGGG)n in telomeres inhibits the telomerase access, and
G-quadruplex-interactive small molecules have been shown to stabilize the G-quadruplex structures
and inhibit telomerase activity, as well as disrupt telomere maintenance [5,6]. The natural product
protoberberines are a class of alkaloids that interact with nucleic acids and have anticancer activities [7].
Studies have shown that berberine and its derivatives inhibit telomerase and have selectivity for the
human telomeric G-quadruplex relative to duplex DNA [8]. We have previously found that among
the several structurally similar protoberberines, epiberberine (EPI) (Figure 1a) exhibits the greatest
fluorescence enhancement upon binding to human telomeric G4 in K+ solution, up to 45 times stronger
than other G4s and double-stranded DNA [9]. However, it was unclear how the alkaloids bind the
human telomeric G4, as the structures of both hybrid-1 and hybrid-2 human telomeric G4s contain no
obvious binding pocket to accommodate the large tetracyclic alkaloids, with both the 5′- and 3′-ends of
the DNA occupied by disordered flanking segments. This has been solved by our recently published
NMR study, which reveals that EPI recognizes specifically the hybrid-2 form of the human telomeric
G4, and most strikingly, upon binding, EPI converts other forms of the telomeric G4s to the hybrid-2
structure [6]. The NMR structure of the EPI in complex with the hybrid-2 form of the human telomeric
G4 shows that the EPI binding induces complete rearrangements of the 5′-flanking segment and loop
regions leading to the formation of a highly extensive four-layered binding pocket at the 5′ end of
G4 [6]. Interestingly, the three structurally similar protoberberines, berberine (BER), palmatine (PAL)
and coptisine (COP) (Figure 1), which share the same heterocyclic core and differ only in the positions
of a methylenedioxy moiety and two methoxy groups located at the two ends, bind the hybrid-2
telomeric G4 much weaker than EPI [9]. While the NMR structure provides some clues for superior
binding of EPI, it only provides a qualitative explanation but not the quantitative measure of the
binding affinity. Moreover, it is a static structure whereas at room temperature molecules undergo
constant thermal motion in solution. It is therefore important to examine the ligand selectivity when
the thermal fluctuation in conformational dynamics is taken into account.
To more quantitatively examine the molecular recognition of protoberberines by the human
telomeric G4, in the present study we employ two molecular dynamics binding free energy methods,
MM-PB(GB)SA [10–12] (molecular mechanics Poisson Boltzmann/Generalized Born surface area)
and DDM [13–16] (double decoupling method) to compute the binding free energies of the four
protoberberines for the hybrid-2 human telomeric G4 wtTel26 [2]. We compare the calculated binding free
energies with the experimental binding affinities determined in this study using fluorescence. From the
energetic decomposition of the computed binding free energies and the MD (molecular dynamics)
simulated structures, we seek to gain insights into the mechanism of the ligand selectivity. Ideally, the
FEP [17,18] (free energy perturbation) method is best suited to compute the relative binding free energies
for structurally similar ligands. However, for the four protoberberines shown in Figure 1a, the chemical
modifications that convert one ligand to another require ring breaking. Such perturbations involving
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chemical bond breaking and creation is known to be difficult to converge in FEP calculations [19],
although new method development is beginning to make such calculations more feasible [20].
One challenge in computing the binding free energy for DNA-ligand arises from the fact that the
current force fields for simulating nucleic acids are less accurate compared with those used for
simulating proteins [21,22]. Here we compute binding free energies using two widely used Amber
force fields: parm99bsc0 [23] (bsc0) and the more recent variant parm99bsc0OL15 parameters set
(OL15) [24]. One of the goals of the present study is to evaluate how well the computational methods
employing the current DNA force fields capture the experimental trend of the ligand selectivity and
reproduce the NMR structure of the DNA-ligand complex.
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Figure 1. Chemical structures of protoberberine alkaloids: (a) epiberberine (EPI), (b) berberine (BER),
(c) coptisine (COP) and (d) palmatine (PAL).
2. Results and Discussions
2.1. The MM-PB(GB)SA Binding Free Energies Calculated from Molecular Dynamics Simulations Correlate
Well with Experimental Binding Affinities
We utilize the NMR structure of the complex of EPI with the wild-type human telomeric G4
sequenc wtTel26 (TTA[Q]TT, [Q] = 5′-G3(TTAG3)3-3′) to investigate the molec lar mechanism of
th ligand selectivity in the recognition of protoberberines by the human telomeric G4. The NMR
structure shows that the EPI binding i duces complet rearrangem nts of the 5′ end flanking and loop
segments leading to the formation of a highly extensive four-layer d binding pocket at the 5′ end of
hybrid-2 human telomeric G4 [6] (Figure 2). The four s ructurally similar protoberberine alkaloids:
EPI, berberine (BER), p lmatine (PAL) and coptisin (COP), share the same heterocyclic core and differ
only in the positions of a methylenedioxy moiety and two methoxy groups locat d at the two ends
(Figure 1). However, the fluoresce ce binding affinity measur ments performed here show th EPI
binds wtTel26 at least 20 times grea er than the other three protoberberines (Figure 3). The NMR
structure provides some clues for superior binding of EPI. For xample, in the NMR structure, the EPI
forms H-bond (Figure 2) w th A3 through its methyl nedioxy ring E (Figure 1a); in BER and PAL, the
methylenedioxy is replaced y methoxy groups which could weaken the H-bond w th A3. In addition,
in BER and COP the methylenedioxy ing at the oth r end may cause steric clash s with the DNA
backbone (Figure 2).
We first us molecular dynam cs binding free energy method MM-PB(GB)SA to calculate the
absolute binding free energy for each liga . One potential challenge in estimating the binding free
energy of protoberberin s with the human telomeric G4 could come from the very large conformational
change induced by the ligand binding (Figure 2). H re, the more approximate MM-PB(GB)SA has one
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advantage in that it is an end-point method, which does not need to sample the intermediate states
connecting the two end states.Molecules 2019, 24, x  4  of  14 
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i . ( ) Fluorescence intensity of four protoberberines (0.2 µM) upon titration with tTel26 DNA,
showing 1:1 binding by the curv fitting (solid line). Conditions: 25 ◦C, pH 7, 100 mM K+. (B) The
determined disassociation c sta t (Kd) values of the EPI, COP, PAL, BER.
i i i t l i l it t f l l i i t -
t it t f r fi l ar s i T l 1. The results of ( - ) ( at not sho n)
essentially the same as ∆G( M-GBSA). As seen from Table 1, the calculated ∆G(MM-GBSA)
for EPI (−53.3 kcal/mol) is the most favorable among the four alkaloids, in agr ement ith
i l i i i . T l ls s s t at the calculated ( - f
i t t t r li a s, a i i agree t it t e ex eri e t l e s r
i 3). Figure 4 shows the correlation between the calculated ∆G(MM-GBSA) with the experimental
binding affinities. The R2-value of 0.69 shows that the computational results c rre ate well with th
experimental data.
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Table 1. MM-GBSA binding free energies and their components computed using the bsc0 force field [23].
Units: kcal/mol.
Ligand ∆E(vdw) ∆E(elec) ∆G(solv_elec) ∆G(solv_np) ∆G(MM-GBSA) a ∆G(total_elec) a ∆G(total_np) a
BER −46.8 ± 0.1 −539.1 ± 10.3 554.9 ± 11.5 −3.0 ± 0.1 −33.9 ± 1.2 15.9 ± 1.1 −49.8 ± 0.0
COP −59.4 ± 0.4 −561.1 ± 0.2 582.0 ± 0.8 −3.6 ± 0.2 −42.1 ± 0.5 20.9 ± 1.0 −63.0 ± 0.5
EPI −68.1 ± 0.2 −579.2 ± 0.5 598.0 ± 0.6 −4.0 ± 0.0 −53.3 ± 0.4 18.8 ± 0.1 −72.1 ± 0.2
PAL −65.2 ± 2.4 −573.8 ± 5.0 595.6 ± 5.2 −4.5 ± 0.1 −47.9 ± 2.4 21.8 ± 0.2 −69.7 ± 2.5
a The binding free energy ∆G(MM-GBSA) = ∆E(vdw) + ∆E(elec) + ∆G(solv_elec) + ∆G(solv_np) = ∆G(total_elec) +
∆G(total_np). ∆E(vdw): the van der Waals energy contribution; ∆E(elec): the direct receptor-ligand electrostatic
interaction energy; ∆G(solv_elec): the electrostatic component of the solvation free energy; ∆G(solv_np): the
nonpolar component of the solvation free energy; ∆G(total_elec): the total electrostatic contribution to binding free
energy, which comprises ∆E(elec) and ∆G(solv_elec), i.e., ∆G(total_elec) = ∆E(elec) + ∆G(solv_elec); ∆G(total_np):
the total nonpolar contribution to binding free energy, which consists of ∆E(vdw) and ∆G(solv_np), i.e., ∆G(total_np)
= ∆E(vdw) + ∆G(solv_np).
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2.2. The MM-PB(GB)SA Binding Free Energies Calculated Using Single Energy-Minimized Structures Show
No Correlation with the Experimental Data
We have also calculated the MM-PB(GB)SA binding free energies using single energy-minimized
structure of the ligand-DNA complexes. Such calculations ignore the dynamic effect in receptor-ligand
binding, but because it is computationally fast, the protocol is widely used for rapid in silico screening of
ligand binding [25]. However, our result shows that there is no correlation between the MM-PB(GB)SA
free energy calculated using the single minimized structure and the experimental binding affinities of
protoberberine-wtTel26 G4 binding (data not shown). This result is in contrast with the MM-PB(GB)SA
binding free energies calculated using snapshots from molecular dynamics simulations, which show
good correlation with the experiments (Figure 4). These results therefore demonstrate that the dynamic
ligand-DNA conformational coupling plays a crucial role in the ligand selectivity of the protoberberine
recognition by the wtTel26 G4. While the single minimized structure MM-PB(GB)SA protocol may
work for ligand binding with more rigid binding sites found in many protein-ligand systems, the
ligand-DNA complexes in this report are quite flexible such that molecular dynamics sampling is
clearly needed to account for the conformational flexibility in order to capture the experimental trend
in the ligand selectivity.
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2.3. MM-PB(GB)SA Free Energy Calculated Using MD with OL15 Force Field also Reproduced Experimental
Trend Well but the Simulations Show Structural Distortion in the Protoberberine Binding Site
To examine how the calculated binding free energies depend on the choice of the DNA force field,
we performed the molecular dynamics MM-PB(GB)SA calculations using the more recent DNA force
field OL15 [24], which contains more refined sugar-phosphate backbone torsion and the χ glycosidic
torsion parameters that improved the simulation of the Z-DNA and B-DNA. As shown in Table 2,
the ∆G(MM-GBSA) binding free energies calculated using OL15 also correctly ranked EPI as the top
binder, and the ranking order of the ∆G(MM-GBSA) is the same as that obtained using bsc0 (Table 1).
However, the differences in the ∆G(MM-GBSA) binding free energies separating strongest binders
(EPI) and other compounds are substantially smaller than those obtained with the bsc0 force field
parameters set: See Tables 1 and 2. For example, the ∆G(MM-GBSA) for EPI and PAL calculated
using bsc0 differ by −5.4 kcal/mol, whereas the same quantities calculated using OL15 differ by just
−2.4 kcal/mol.
Although there is a good correlation between the ranking order of ∆G(MM-GBSA) obtained
using OL15 and the experimental binding affinities, the snapshots from the MD simulations reveal
that the simulated-structure of the ligand binding site region is distorted compared with the NMR
structure of the EPI-wtTel26 G4 complex [6], particularly in the simulations using the OL15 parameters.
Figure 5 shows the binding site structures according to NMR and simulations. It can be seen that
the four-layered binding pocket found in the NMR structure is distorted in the OL15 simulation.
In particular, in the NMR structure, the T13/T14 base planes are parallel to the plane of EPI aromatic
ring system, whereas in the OL15-simulated structure, the T13/T14 bases are perpendicular to the EPI
plane. Structural deviations from the experimental structure are also observed in the bsc0-simulated
structure: For example, the orientation of the A21 base shifts by 45 degrees from that in the NMR
structure (Figure 5). However, compared with OL15-simulated structure, the binding pocket in the
bsc0-simulated structure appears to be better preserved. Although we have observed structural
deviations from the NMR structure of the EPI-wtTel26 G4 complex using both DNA force fields, we
caution that these observations regarding the performance of the force fields may not necessarily
apply to other systems, since MD simulations of DNA-ligand complexes can be sensitive to a number
of factors, including the DNA topology in the ligand binding site as well as the nature of ligand.
For example, Wu et al. [26] have used OL15 to accurately model the binding of BRACO19, a much
larger ligand with the parallel stranded human telomeric G-quadruplex, which has a very different
topology from the hybrid-2 human telomeric G4 studied here.
Table 2. MM-GBSA Binding free energies and their components computed using the Amber force field
OL15 parameters. Units: kcal/mol.
Ligand ∆E(vdw) ∆E(elec) ∆G(solv_elec) ∆G(solv_np) ∆G(MM-GBSA) ∆G(total_elec) ∆G(total_np)
BER −60.7 ± 2.6 −557.2 ± 5.9 577.4 ± 6.2 −4.1 ± 0.1 −44.6 ± 2.2 20.2 ± 0.3 −64.8 ± 2.5
COP −60.9 ± 1.7 −566.5 ± 2.9 585.4 ± 2.6 −3.4 ± 0.0 −45.3 ± 2.1 18.9 ± 0.3 −64.3 ± 1.7
EPI −64.7 ± 0.9 −573.4 ± 3.2 592.4 ± 3.9 −4.1 ± 0.0 −49.9 ± 0.2 19.0 ± 0.7 −68.8 ± 0.9
PAL −67.2 ± 0.4 −581.3 ± 1.3 605.4 ± 5.2 −4.4 ± 0.1 −47.5 ± 0.8 24.1 ± 0.4 −71.6 ± 0.5
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Figure 5. Comparison of the (left) NMR structure with the MD snapshots taken at 10 ns from the
simulations using (center) OL15 and (right) bsc0 force field parameters. For clarity, only the nucleotide
bases forming the 5′ binding site and the G-tetrads are displayed. The green dashed line indicates the
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2.4. Thermodynamic Driving Force for the Protoberberine-wtTel26 Binding
To gain further insights into the general thermodynamic driving force in the protoberberine-wtTel26
G4 binding, we examined the binding free energy contributions given by the MM-PB(GB)SA (Table 1).
Since the structures simulated using bsc0 is in better agreement with the experimental structure, the
energetics and trajectory analysis discussed below are based on the bsc0 results. It can be seen that the
binding is favored by the ligand-DNA van der Waals interaction ∆E(vdw), the electrostatics interaction
∆E(elec), and to a lesser extent the buried surface area term ∆G(solv_np) (Table 1). The favorable
∆E(vdw) reflects the extensive stacking interaction between the ligands and the DNA binding pocket
induced by the ligand: See Figure 6. The very large electrostatic interaction ∆E(elec) of ~ −550 kcal/mol
arises mainly from the Coulomb attraction between the oppositely charged EPI (+1e) and DNA
(−23e, including two channel K+ cations). Table 1 also shows that the binding is strongly opposed
by the electrostatic desolvation free energy ∆G(solv_elec) which more than cancels out the large
electrostatic interaction ∆E(elec). As a result, the net electrostatic contribution ∆G(total_elec) to binding
is unfavorable, at around +20 kcal/mol. Overall, the binding is driven by the net nonpolar interaction,
∆G(total_np), which is the sum of ∆E(vdw) and ∆G(solv_np) and opposed by the net electrostatic
contribution ∆G(total_elec).
2.5. Binding Free Energy Components and MD Trajectory Analysis Help Rationalize the Ligand Selectivity
Among the four alkaloids, EPI has the most favorable ligand-DNA van der Waals interaction
∆E(vdw) (−68.1 kcal/mol) and electrostatics interaction ∆E(elec) (−579.2 kcal/mol). Therefore, the ligand
selectivity that favors EPI over other compounds is determined by both the more optimal van der
Waals packing and ligand-DNA electrostatics interactions between EPI and wtTel26. To understand
the structural origin of these two factors, we look at the ligand-DNA interaction diagram abstracted
from the NMR structure for the EPI-wtTel26 complex: See Figure 6. The EPI-wtTel26 complex is
stabilized by a number of stacking interactions from G12/G13 and A15/G16; these are reflected by the
favorable ∆E(vdw) of −68.1 kcal/mol for EPI (Table 1). The PAL and COP have weaker ∆E(vdw) of
−65.2 kcal/mol and −59.4 kcal/mol, respectively, while BER has the weakest ∆E(vdw) at −46.8 kcal/mol.
Examining the MD trajectories, we find that these ∆E(vdw) values correlate with the structural stability
of the ligand-DNA complex (Figure 7). As shown in Figure 7, the root-mean-squared deviations
(RMSD) from the starting complexes are in the order EPI < PAL ≤ COP BER, i.e., consistent with the
decreasing van der Waals packing seen in the ∆E(vdw) values. The larger RMSD fluctuations in the
MD trajectory of BER (Figure 7, left panel) are also consistent with its weaker experimental binding
affinity compared with the other compounds (Figure 3).
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Next, we look at the structural factors that differentiate the electrostatics interaction ∆E(elec)
among the different ligands (Table 1). The order of ∆E(elec) is EPI ≤ PAL < COP BER. The ∆E(elec)
for BER is much weaker than other ligands by more than 20 kcal/mol, which is clearly related to the
instability in the binding pocket containing BER: See Figure 7, left panel. Among the other three ligands,
the EPI exhibits the strongest ∆E(elec), which can be attributed to the H-bond between the EPI:O3 and
N6 of A3 (Figure 6) that appears to play an important role in the more favorable electrostatic interaction
∆E(elec) in EPI relative to that in COP and PAL. To investigate the stability of the EPI:O3-A3:N6 H-bond
in the MD simulations, we examine the distance between the EPI:O3-A3 along the MD trajectories:
See Figure 7, right panel. Among the four compounds, only EPI maintains EPI:O3-A3:N6 H-bond
throughout the entire MD trajectory (formed in ~92% of the time). In the PAL-wtTel26 complex, the
PAL:O3-A3:N6 hydrogen bond is present in less than 35% of the time. This is consistent with the fact
that the electrostatic interaction ∆E(elec) for the PAL binding, despite its relatively large fluctuation, is
on average about 5 kcal/mol weaker compared with that in the EPI binding (Table 1). In the complexes
containing COP and BER, the ligand-A3 H-bond is completely absent, which contributes to their
significantly weaker ∆E(elec) relative to that of EPI and PAL (Table 1).
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2.6. NMR Titration Shows that Among the Protoberberines Studied Here Only EPI Binds Specifically to the
Hybrid-2 Human Telomeric G4
We conducted 1D 1H-NMR titration experiments for the four protoberberine alkaloids to wtTel26.
Figure 8 shows the 1H-NMR imino region of titrating the four compounds BER, COP, EPI and PAL
to wtTel26. It can be seen that only EPI forms well-defined complex with wtTel26 as demonstrated
by its well-resolved spectra lines upon addition of ligand to free DNA. The observation of peaks
corresponding to both the free DNA and the EPI:wtTel26 at 0.5eq EPI complex indicates EPI binding
has a slow exchange rate on the NMR time scale, which is characteristic of ligands binding with high
affinity and specificity. In contrast, the addition of the other compounds BER, COP or PAL results in
the broadening of peaks corresponding to free DNA, indicative of less-specific binding which occurs
with a medium exchange rate on the NMR time scale. Notably, the peak occurring at 12.6 ppm in the
wtTel26:EPI complex, corresponding to the formation of the T13 hydrogen-bonded capping structure
in the EPI complex, was not observed in the other complexes [6]. Taken together, the NMR results
suggest that compared with EPI, the other compounds exhibit less-optimal binding interactions with
wtTel26, consistent with the calculated binding free energies (Tables 1 and 2).
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2.7. The More Rigorous DDM Calculations Make Incorrect Predictions for the Top Binder of the Hybrid-2
Human Telomeric G4
We have also evaluated the performance of the more rigorous DDM method in estimating the
absolute binding free energy ∆Gobind for protoberberine-wtTel26 G4 binding (Table 3). The DDM
calculation is carried out using the bsc0 force field. The performance of the DDM results is mixed:
On the one hand, the absolute magnitudes of the calculated ∆Gobind are quite reasonable. For example,
the calculated ∆Gobind for EPI:wtTel26 binding is −8.9 ± 0.4 kcal/mol, which is similar in magnitude to
experimental free energy of −10.7 ± 0.02 kcal/mol. On the other hand, the DDM calculation incorrectly
predicts EPI as the second-best binder after COP. Thus, the calculated ∆Gobind exhibits a poor correlation
with the experimental binding free energies with R2 = 0.17. One potential challenge in estimating
the binding free energy of protoberberines with the human telomeric G4 could come from the large
conformational change induced by the ligand binding (Figure 2), which could be one source of error in
the DDM calculation. This is because the an accurate DDM calculation requires correctly sampling the
entire alchemical pathway connecting the complexed and dissociated states, which includes many
intermediate states. In the wtTel26 G4, the binding site region near the 5′-end adopts completely
different conformations in the complexed [6] and the unbound state [27] (Figure 2); and sampling
reversibly such large reorganization in nanoseconds MD simulation can be challenging. In contrast,
the MM-PB(GB)SA method requires only the two end-states, the complexed and unbound states,
to be sampled accurately; there is no need to sample reversibly the many intermediate states along
the alchemical pathway connecting the two end points. This could explain why the results from
the more empirical MM-PB(GB)SA method yield better agreement with the experiments for these
DNA-ligand complexes.
Table 3. The DDM-calculated absolute binding free energies ∆Gobind of ligand binding to wtTel26.
Unit: kcal/mol.
Ligand −∆G(complex) ∆G(solvent) ∆Grestr–on ∆Gobind a ∆Gobind(expt) a
BER −42.8 ± 0.5 27.9 ± 0.0 7.3 −7.6 ± 0.5 −7.82 ± 0.06
COP −45.9 ± 0.8 28.5 ± 0.1 7.3 −10.1 ± 0.8 −8.89 ± 0.1
EPI −43.3 ± 0.4 27.1 ± 0.0 7.3 −8.9 ± 0.4 −10.70 ± 0.02
PAL −40.3 ± 0.3 24.6 ± 0.1 7.3 −8.4 ± 0.3 −8.41 ± 0.01
a ∆Gobind = −∆G(complex) + ∆G(solvent) + ∆Grestr–on; b Obtained from the experimentally determined Kd:
see Figure 3.
3. Materials and Methods
3.1. Fluorescence Measurements of the Binding Dissociation Constant
Fluorescence spectra were acquired using a Jasco-FP8300 spectrofluorometer (Jasco Inc.,
Easton, MD, USA) equipped with a temperature-controlled circulator. Fluorescence was measured in a
quartz cell with path length of 1 cm, using an excitation wavelength of 377 nm and an emission spectra
scan from 520–600 nm. The titration experiments were carried out at protoberberine concentrations
of 0.2 µM in 100 mM K+. wtTel26 DNA at the specified concentrations was titrated into the four
protoberberine solutions, respectively, and the resulting solutions were incubated for 2 min before
fluorescence measurements were taken. The disassociation constant Kd was calculated using GraphPad
Prism software (San Diego, CA, USA fitting of an equation: A = Amin + (Amax − Amin) [(PT + OT +
Kd) − [((PT + OT + Kd)2 − (4PTOT))1/2]/(2OT), where A represents the fluorescence intensity of the
protoberberines bound to wtTel26 DNA. Both Amax and Amin are fit in addition to Kd. The protoberberine
concentration, OT, was held constant, and PT, the total complex concentration is the independent
variable, varying with each measurement of A.
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3.2. NMR Titration
wtTel26 DNA oligonucleotides were synthesized and purified as previously described [6] using
commercially available reagents. Oligonucleotide samples were prepared to a final concentration of
100–250 µM in buffer solution containing 25 mM potassium phosphate, 70 mM potassium chloride
and 90/10% H2O/D2O at pH 7. Samples were heated to 95 ◦C for 5 min then cooled slowly to room
temperature for G-quadruplex formation. wtTel26 DNA was quantified by UV/Vis spectroscopy at
260 nm using its calculated extinction coefficient (261,200 L mol−1 cm−1). Ligand stock solutions
were prepared at 40 mM in deuterated DMSO and titrated into the DNA solution to the desired
concentrations for the complex samples. NMR experiments were conducted using a Bruker DRX-600
spectrometer or AV-500 (Billerica, MA, USA) spectrometer with cryoprobe. All experiments were
performed using Watergate water suppression. 1D 1H-NMR spectra were collected at 25 ◦C.
3.3. MD Setup and MM-PB(GB)SA Calculation
The starting structure for the molecular dynamics simulations is the solution NMR structure
of the EPI-hybrid-2 human telomeric G-quadruplex (PDB entry 6ccw). The initial structures of the
ligand-DNA complexes containing other three ligands (BER, COP and PAL) are modeled based on the
NMR structure of the EPI-G4: note that these three compounds share the same heterocyclic core of the
EPI; and they differ only in a methylenedioxy moiety and two methoxy groups located at the two ends
(Figure 1). Therefore, starting from the NMR structure of the EPI-wtTel26 complex (Figure 2), the bound
structures of the three weaker ligands are obtained by manually modifying the bonds at the two ends
of the EPI structure in the binding pocket. Although there are no direct experimental information
about the binding modes of these three weaker ligands BER, COP and PAL, the calculated binding free
energies using the simulations starting from the modeled initial structures of the complexes correlate
well with the experimental binding affinity (Figure 4). This indirectly supports the modeled initial
structures of the three weaker compounds.
The MM-PB(GB)SA binding free energy simulations were performed using the AMBER16
program [28]. As discussed earlier, the AMBER parm99bsc0 [23] force field and the more recent
OL15 [24] modifications are used to model the G-quadruplex DNA in aqueous solutions. The four
protoberberine compounds are modeled by the Amber GAFF parameters set [29] and the AM1-BCC
charge model [30]. A truncated octahedral box containing TIP3P [31] water molecules was used to
solvate the ligand-DNA complexes. The solvent box is set up to ensure that the distance between solute
atoms from nearest walls of the box is at least 10 Å. K+ ions are added to the solvent box to maintain
charge neutrality. The electrostatic interactions were computed using the particle-mesh Ewald (PME)
method [32] with a real space cutoff of 10 Å and a grid spacing of 1.0 Å. A 2 fs time step is used for
MD simulations. Before the production run, the system is equilibrated in a number of steps. First the
energy minimized system is heated from 0 K to 300 K in 200 ps, while the solute atoms are restrained
with a force constant k = 10 kcal/Å2 mol. Then the system is equilibrated for 8 ns with decreasing
harmonic restraints: 2 ns with k = 5 kcal/Å2 mol, 2 ns with k = 1 kcal/Å2 mol, 2 ns with k = 0.25 kcal/Å2
mol, and 2 ns with k = 0.05 kcal/Å2 mol. Finally, a production MD of 10 ns is run in the NPT ensemble
using the Langevin thermostat and isotropic position scaling for constant pressure (NTP = 1).
The MM-PB(GB)SA binding free energy [10,12] is computed using the one-trajectory protocol
implemented by the MMPBSA.py [33] in the Amber16 release (The one-trajectory MM-PBSA is
generally considered more robust compared with the three-trajectory MM-PBSA approach). Briefly,
the binding free energy ∆Gbind is computed as the difference between the free energy of the complex
and that of the two receptor and ligand
∆Gbind = G(complex) − G(receptor) − G(ligand) (1)
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The free energy of species X, G(X), is approximated as
G(X) = E(bonded) + E(elec) + E(vdw) + G(solv_elec) + G(solv_np) − TS(solute) (2)
Combining Equations (1) and (2) and using the one-trajectory approximation yields
∆Gbind ≈ ∆E(vdw) + ∆E(elec) + ∆G(solv_elec) + ∆G(solv_np) − T∆S (3)
The solute entropy term T∆S is sometimes approximated by normal mode entropy [25], but
such treatment rarely leads to improvement in the correlation with experiments. In this work we
do not include the solute entropy term T∆S in estimating ∆Gbind. The electrostatic solvation free
energy contribution ∆G(solv_elec) in Equation (3) is approximated using the continuum electrostatics
Poisson-Boltzmann (PB) or Generalized Born (GB) approaches. The nonpolar solvation free energy
∆G(solv_np) is approximated by a solvent accessible surface area term.
The OBC-GB [34] (igb = 2 in AMBER) model is used to compute the MM-GBSA energy, with the
ionic concentration set to 0.1 M. The mbondi2 radii set was used for the atomic radii in GB.
3.4. DDM Calculation
In DDM [13–15,35], the absolute binding free energy is computed using
∆Gobind = −∆G(complex)+∆G(solvent)+∆Grestr–on (4)
Here ∆G(complex) includes the free energy of turning on a set of geometrical restraint when the
ligand is bound [14], as well as the free energy of turning off the ligand interactions with its environment.
∆G(solvent) is the free energy of turning off the ligand-solvent interactions when the ligand is in the
bulk solution. In addition, ∆Grestr–on is the free energy of turning on the set of geometrical restraints for
an alchemically decoupled ligand. While ∆G(complex) and ∆G(solvent) are computed using simulation,
the ∆Grestr–on is computed analytically [35].
The DDM calculation is performed using the GROMACS program [36,37]. The DNA molecule is
described using the bsc0 force field and the ligands are described using the Amber GAFF parameters
set [29] and the AM1-BCC charge model [30]. The detailed DDM protocol used in this work has been
described previously [14].
4. Conclusions
We performed binding free energy calculations, fluorescence binding affinity measurements, and
NMR titrations to investigate the underlying molecular basis for the ligand selectivity in the recognition
of the hybrid-2 human telomeric G-quadruplex by protoberberines. The ligand molecules studied here
have similar chemical structures but displayed markedly different binding affinities for the hybrid-2
human telomeric G4 (Figure 3). The binding free energies computed using the MM-PB(GB)SA are
consistent with experimental binding affinity measurements and NMR titration experiments performed
in this study. The results show that, in order to reproduce the experimental ligand selectivity in
computation, it is crucial to account for the conformational flexibility in the ligand-DNA complexes in
the binding free energy calculation. The analysis of the MD trajectories shows that, compared with
other compounds, EPI has more optimal interactions with the 5’-pocket, including the high occupancy
of the intermolecular H-bond with A3 in the binding site. We have examined the possible force field
dependence of the binding free energy simulation and found structural deviations from the NMR
structure in the binding site region in the simulations performed with both the more recent OL15 and
the older bsc0 DNA force fields. While the performance of the OL15 force field has been examined
on lateral and diagonal loops of the apo human telomeric G4 in extended simulations [21], the force
field has yet to be extensively examined for simulating various loop conformations where ligands
can bind, such as the one shown in this study. We have also found that, in the presence of very large
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ligand-induced conformational reorganization, the alchemical pathway method DDM may suffer from
sampling problems, whereas the more empirical end-point method MM-PB(GB)SA actually performed
better in capturing the ligand selectivity in these DNA-ligand systems. This study provides insights
into the molecular determinants underlying the recognition of protoberberines by the human telomeric
G4, and shed lights on the strengths and limitations of various binding fee energy methods and the
DNA force fields currently used in the structure-based drug discovery targeting G-quadruplex DNA.
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